Arcus Biosciences, Inc. Common Stock (RCUS)

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company focused on the development of innovative therapies for cancer treatment

The company specializes in creating a diverse portfolio of drug candidates that target various pathways involved in the immune response and tumor microenvironment, aiming to unlock the potential of the immune system in combating different types of cancers. Through its rigorous research and development efforts, Arcus strives to bring forth effective treatment options for patients and address significant unmet medical needs in oncology.